Compare drug alternatives
Vyepti® Alternatives
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Intravenous infusion (must be diluted)
Subcutaneous
Dosing
100 mg every 3 months or 300 mg (for some patients)
70 mg once monthly or 140 mg once monthly (for some patients)
Latin Shorthand
100 mg q3mo
70 mg/mo or 140 mg/mo
Financial Assistance
Copay
$0
$5
Annual Cap
$200 per infusion for administration costs
Patient specific maximum benefit.
Assistance Expiration
Calendar year
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available